{
  "ticker": "CRL",
  "last_updated": "2025-05-30T08:33:24.280711",
  "retention_years": 3,
  "count": 12,
  "transactions": [
    {
      "id": 211,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-05-26",
      "transaction_shares": "161",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "19352"
    },
    {
      "id": 212,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-05-26",
      "transaction_shares": "104",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "7608"
    },
    {
      "id": 213,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-05-26",
      "transaction_shares": "281",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "54347"
    },
    {
      "id": 214,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-05-26",
      "transaction_shares": "50",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "8805"
    },
    {
      "id": 215,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-05-26",
      "transaction_shares": "190",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "10471"
    },
    {
      "id": 218,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-05-26",
      "transaction_shares": "123",
      "transaction_price": "136.73",
      "transaction_type": "F",
      "shares_after_transaction": "16383"
    },
    {
      "id": 216,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "MACKAY MARTIN",
      "reporting_owner_cik": "0001414815",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "13477"
    },
    {
      "id": 217,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Llado George Sr.",
      "reporting_owner_cik": "0001829162",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "4295"
    },
    {
      "id": 219,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WILSON VIRGINIA M",
      "reporting_owner_cik": "0001262696",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "4911"
    },
    {
      "id": 220,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "2413"
    },
    {
      "id": 221,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Andrews Nancy C",
      "reporting_owner_cik": "0001804999",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "3964"
    },
    {
      "id": 222,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2025-05-21",
      "transaction_shares": "946",
      "transaction_price": "134.98",
      "transaction_type": "A",
      "shares_after_transaction": "1960"
    }
  ]
}